×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Cyclerion Therapeutics Inc. (CYCN) NASDAQ

$2.69 0.41 (17.98%)

Market Cap: $7.29M

As of 06/21/24 04:00 PM EDT. Market closed.

(CYCN)

Cyclerion Therapeutics Inc. (CYCN)
NASDAQ

$2.69
0.41 (17.98%)

Market Cap: $7.29M

As of 06/21/24 04:00 PM EDT. Market closed.

Add to Portfolio

cyclerion therapeutics, inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. its product candidates include olinciguat, an orally administered vascular soluble guanylate cyclase (sgc) stimulator that is in phase ii studies for the treatment of sickle cell disease (scd); praliciguat, ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$100,000
URL
Address
.
PRICE CHART FOR CYCLERION THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.96
Previous Close
$2.28
Days Range
$1.92 - $2.70
52 week range
$1.75 - $5.25
Volume
19,212
Avg. Volume (30 days)
6,231
Market Cap
$7.29M
Dividend Yield
-
P/E
(0.68)
Shares Outstanding
2,710,096
Open
$1.96
Previous Close
$2.28
Days Range
$1.92 - $2.70
52 week range
$1.75 - $5.25
Volume
19,212
Avg. Volume (30 days)
6,231
Market Cap
$7.29M
Dividend Yield
-
P/E
(0.68)
Shares Outstanding
2,710,096
FINANCIAL STATEMENTS FOR CYCLERION THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CYCLERION THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MCGUIRE TERRANCEDirectorAug 09, 2023 Sale$3.398270Aug 11, 2023, 04:25 PM
Hecht Peter MChief Executive OfficerMay 19, 2023 Option Exercise$8.68225,0001,953,000327,385May 22, 2023, 08:43 PM
MCGUIRE TERRANCEDirectorJun 03, 2021 Buy$3.123,32210,36524,957Jun 07, 2021, 05:36 PM
MCGUIRE TERRANCEDirectorJun 03, 2021 Buy$3.1292,831289,633697,313Jun 07, 2021, 05:36 PM
Hecht Peter MChief Executive OfficerJun 03, 2021 Buy$3.28823,1702,699,9982,047,698Jun 07, 2021, 05:25 PM
Hecht Peter MChief Executive OfficerMay 06, 2021 Buy$2.43302,000733,8601,224,528May 10, 2021, 08:45 AM
Hecht Peter MChief Executive OfficerMay 05, 2021 Buy$2.53398,0011,006,943922,528May 06, 2021, 09:27 PM
Hecht Peter MChief Executive OfficerMay 04, 2021 Buy$2.29300,000687,000524,527May 06, 2021, 09:27 PM
Gjino AnjezaChief Financial OfficerFeb 25, 2021 Sale$4.001,8247,29631,599Mar 01, 2021, 04:23 PM
Wright Christopher IChief Medical OfficerFeb 25, 2021 Sale$3.992,63710,52242,728Mar 01, 2021, 12:00 AM
Currie Mark GPresident and CSODec 28, 2020 Sale$3.0120,10760,522251,648Dec 30, 2020, 01:14 PM
Busch AndreasChief Innovation OfficerNov 09, 2020 Buy$2.53125,000316,250254,704Nov 12, 2020, 05:05 PM
Huyett WilliamChief Financial OfficerNov 06, 2020 Sale$2.523,8279,64467,590Nov 10, 2020, 07:07 PM
Huyett WilliamChief Financial OfficerFeb 21, 2020 Sale$5.123,55918,22271,417Feb 25, 2020, 04:11 PM
Currie Mark GPresidentDec 30, 2019 Sale$2.4825,00062,000271,755Dec 31, 2019, 05:55 PM
Currie Mark GPresidentDec 27, 2019 Sale$2.5525,00063,750296,755Dec 31, 2019, 05:55 PM
Busch AndreasChief Innovation OfficerNov 15, 2019 Buy$1.82125,000227,500125,000Nov 19, 2019, 04:02 PM
Huyett WilliamChief Financial OfficerNov 08, 2019 Sale$2.053,9228,04074,976Nov 12, 2019, 04:26 PM
Hecht Peter MChief Executive OfficerJul 10, 2019 Option Exercise$6.042,00012,080225,192Jul 12, 2019, 04:09 PM
MCGUIRE TERRANCEDirectorApr 08, 2019 Buy$16.0021,635346,16021,635Apr 10, 2019, 04:14 PM
MCGUIRE TERRANCEDirectorApr 08, 2019 Buy$16.00604,4829,671,712604,482Apr 10, 2019, 04:14 PM
SCHULMAN AMY WDirectorApr 08, 2019 Buy$16.0021,635346,16021,635Apr 10, 2019, 04:13 PM
SCHULMAN AMY WDirectorApr 08, 2019 Buy$16.00604,4829,671,712604,482Apr 10, 2019, 04:13 PM
Currie Mark GPresidentApr 02, 2019 Buy$14.81270,1074,000,285321,755Apr 03, 2019, 07:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MCGUIRE TERRANCEDirector08/09/202327
Hecht Peter MChief Executive Officer05/19/20231,953,000
MCGUIRE TERRANCEDirector06/03/202110,365
MCGUIRE TERRANCEDirector06/03/2021289,633
Hecht Peter MChief Executive Officer06/03/20212,699,998
Hecht Peter MChief Executive Officer05/06/2021733,860
Hecht Peter MChief Executive Officer05/05/20211,006,943
Hecht Peter MChief Executive Officer05/04/2021687,000
Gjino AnjezaChief Financial Officer02/25/20217,296
Wright Christopher IChief Medical Officer02/25/202110,522
Currie Mark GPresident and CSO12/28/202060,522
Busch AndreasChief Innovation Officer11/09/2020316,250
Huyett WilliamChief Financial Officer11/06/20209,644
Huyett WilliamChief Financial Officer02/21/202018,222
Currie Mark GPresident12/30/201962,000
Currie Mark GPresident12/27/201963,750
Busch AndreasChief Innovation Officer11/15/2019227,500
Huyett WilliamChief Financial Officer11/08/20198,040
Hecht Peter MChief Executive Officer07/10/201912,080
MCGUIRE TERRANCEDirector04/08/2019346,160
MCGUIRE TERRANCEDirector04/08/20199,671,712
SCHULMAN AMY WDirector04/08/2019346,160
SCHULMAN AMY WDirector04/08/20199,671,712
Currie Mark GPresident04/02/20194,000,285
Load More Insider Transactions
FUNDS WITH A POSITION IN CYCLERION THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC32,0820.00001%2.63%Other
BLACKROCK INC.17,1690%No changeOther
CHANGE IN SHARES OUTSTANDING FOR CYCLERION THERAPEUTICS INC
STOCK BUYBACKS FOR CYCLERION THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
1.59%
1Q
03/31/2024
06/30/2023
9.29%
3Q
03/31/2024
09/30/2022
14.72%
6Q

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
1.59%
1Q
06/30/2023
9.29%
3Q
09/30/2022
14.72%
6Q
BUYBACK ANNOUNCEMENT(S) FOR CYCLERION THERAPEUTICS INC
LOADING...